Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?
about
Brain-derived neurotrophic factor and obesity in the WAGR syndromeThe neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats.Age-related changes in plasma levels of BDNF in Down syndrome patients.The multiple life of nerve growth factor: tribute to rita levi-montalcini (1909-2012)The nerve growth factor signaling and its potential as therapeutic target for glaucomaA novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaquesMetabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.Metabolic syndrome and neurotrophins: effects of metformin and non-steroidal antiinflammatory drug treatment.Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats.Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment.Functional Ser205Leu polymorphism of the nerve growth factor receptor (NGFR) gene is associated with vagal autonomic dysregulation in humans.Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.Different circulating brain-derived neurotrophic factor responses to acute exercise between physically active and sedentary subjects.Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques.Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features.The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders.Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte functionBrain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic propertiesThe Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor.Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems.Triactome: neuro-immune-adipose interactions. Implication in vascular biology.Human epicardial fat: what is new and what is missing?Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits.Increase in Levels of BDNF is Associated with Inflammation and Oxidative Stress during Cardiopulmonary Bypass.The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents.Epicardial adipose tissue and signs of metabolic syndrome in children.Differential regulation of brain-derived neurotrophic factor in term and preterm preeclampsia.Physical training and hypertension have opposite effects on endothelial brain-derived neurotrophic factor expression.Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention.Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women With Metabolic Syndrome.Determinants of Blood Brain-Derived Neurotrophic Factor Blood Levels in Patients with Alcohol Use Disorder.Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.Homage to Rita Levi-Montalcini, the queen of modern neuroscience.Relation of epicardial fat thickness to the severity of heart failure in patients with nonischemic dilated cardiomyopathy.Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder.Nerve growth factor interactions with mast cells.Acute Effects of High Intensity, Resistance, or Combined Protocol on the Increase of Level of Neurotrophic Factors in Physically Inactive Overweight Adults: The BrainFit Study.
P2860
Q24644359-71CDC412-A2A2-4866-94C5-B489998C526AQ24817227-D433E0BC-5BE1-4DC8-9C87-5EA96BB4FA2CQ33738867-AF71B8E4-F842-4246-8F96-ACD70AFE5C43Q33974451-77CCC542-F455-48DE-B9C9-656E31D5D98CQ34182180-E3FD935B-CE95-4261-83C3-81D16377C777Q34612732-04C9095F-949D-4EEE-9F7A-304F5E3B0CC7Q34635250-47B52D82-3D0F-40EB-9EC5-B735A512629FQ34666789-46FA9FE1-C22D-4581-89E5-DFB0581EF43FQ35585590-C3A4DC91-778A-48E0-A46A-C0500E4B9597Q35808437-A99D8959-0A80-4934-AC0F-9D9DA5E84D5CQ35960474-489E8B3F-25EF-48CC-B136-BD551DD52E87Q36384149-E70469D5-38D0-4A70-9AB6-4A39864C0246Q36600804-DED7B895-D317-4674-9AA6-8C1F108BE1C8Q37081178-81A16179-4DA2-4D03-845B-7ECB627030FEQ37159655-716AED3A-5610-4B05-9B08-EE1C06F463F5Q37161278-A23133E1-FA17-4069-8E2B-4D849A6E2B5AQ37220454-F4E2748A-04EE-4838-A9D1-D19CEFA6022EQ37294857-FFBFEC1C-99EC-42EA-9DFD-E40C9F81B5B1Q37357741-35CE6B19-2929-497F-8B18-F63A3CE9507CQ37395764-8A1F9C29-0987-4FD0-9502-928F52C28598Q37546022-79E5EA00-C0F6-43E1-BFA2-0DE6487043D6Q37602133-7B578ACA-3BBF-4B2D-A560-59D0BE404F94Q37702548-7E17EA6C-C1EE-47C6-B56C-18584E6FA5D1Q37927148-3FD0B946-9291-401E-8986-74603B4FE5CEQ38761126-5162E230-D4A7-4A63-9D96-BABD18EB7B35Q38808332-F00F8BF2-B399-4BA3-B47C-72C35F0AE237Q39527400-89381A4F-11DD-4C27-9A28-523FB695AFA7Q39618763-A83997F3-832D-41EF-87B4-439B90BF270CQ40513444-B5D2D768-3E46-46D1-A2AC-BF36EB7CC6AAQ45384118-4B1DD049-26DE-4B05-B035-347EA2E3D500Q46072538-8DE36E2F-AAFD-44DA-83B3-8255D087C261Q47829890-557DDE0F-9BE4-4439-AD51-D4E4C8A8574AQ47853926-8BF4CFC8-032A-4C67-BE54-75CA6CD883E7Q47892396-9DEFF4D6-D629-4DD9-B3D8-0D52F0CCE5CAQ48096542-484DB4A4-64D0-4BE8-8B66-8737C7B9C468Q48274161-D35B0E20-9659-4800-998D-DC5232E3ADCFQ48449156-89DB58A9-E380-4CDD-B762-763825E80BA5Q52141135-5EAEB0A4-2AB7-4C33-BA20-F73EFD27BFC8Q53060410-88333E82-63CA-450A-90E9-5BC0A9B03C38Q55689235-2DEB6547-5F60-4BF0-A083-F4210DC7A0DA
P2860
Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@ast
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@en
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@nl
type
label
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@ast
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@en
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@nl
prefLabel
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@ast
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@en
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@nl
P2093
P921
P1476
Neurotrophin presence in human ...... DNF in cardiovascular disease?
@en
P2093
Alessia Antonelli
George N Chaldakov
Ivan S Stankulov
Luigi Aloe
Luigi Manni
Mariyana G Hristova
Peter I Ghenev
P304
P356
10.1016/S0079-6123(03)46018-4
P50
P577
2004-01-01T00:00:00Z